These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22883390)

  • 21. Achieving glycemic control in patients with type 2 diabetes and renal impairment.
    Avogaro A; Schernthaner G
    Acta Diabetol; 2013 Jun; 50(3):283-91. PubMed ID: 23212669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study.
    Solini A; Penno G; Bonora E; Fondelli C; Orsi E; Trevisan R; Vedovato M; Cavalot F; Cignarelli M; Morano S; Ferrannini E; Pugliese G;
    J Am Geriatr Soc; 2013 Aug; 61(8):1253-61. PubMed ID: 23889588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of acarbose on blood glucose and proteinuria in patients with diabetic nephropathy.
    Tomino Y; Shirato I; Horikoshi S; Fukui M; Yamaguchi Y; Yokomatsu M; Ebihara I; Shimada N; Hishiki T; Hirano K; Rinno H; Shiota J; Kuramoto T
    Nephron; 2000 Jun; 85(2):190. PubMed ID: 10867532
    [No Abstract]   [Full Text] [Related]  

  • 24. [The treatment of diabetes in patients with liver and renal impairment].
    Haluzík M
    Vnitr Lek; 2015 Apr; 61(4):304-11. PubMed ID: 25894259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. About the discrepancies between consensus documents, clinical practice guidelines, and legal regulations in the treatment of type 2 diabetes.
    Martínez-Castelao A; Górriz JL; Sola E; Morillas C; Jover A; Coronel F; Navarro-González J; De Álvaro F
    Nefrologia; 2012 Jul; 32(4):419-26. PubMed ID: 22806275
    [No Abstract]   [Full Text] [Related]  

  • 26. Impact of comprehensive diabetes specialty care in the management of older adults with stage 3 or 4 nephropathy.
    Rizvi AA; McLaughlin N
    South Med J; 2009 Sep; 102(9):985. PubMed ID: 19668037
    [No Abstract]   [Full Text] [Related]  

  • 27. [Recommendations for the drug therapy of diabetes type 2. Treatment of associated vascular risk factors. French Agency for the Safety of Therapeutic Products].
    Presse Med; 1999 Oct; 28(29):1584-9. PubMed ID: 10544712
    [No Abstract]   [Full Text] [Related]  

  • 28. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cordyceps militaris Treatment Preserves Renal Function in Type 2 Diabetic Nephropathy Mice.
    Yu SH; Dubey NK; Li WS; Liu MC; Chiang HS; Leu SJ; Shieh YH; Tsai FC; Deng WP
    PLoS One; 2016; 11(11):e0166342. PubMed ID: 27832180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diabetic patient with liver or kidney disease. Which antidiabetics are allowed?].
    Stiefelhagen P
    MMW Fortschr Med; 2010 Jun; 152(22):18. PubMed ID: 20590025
    [No Abstract]   [Full Text] [Related]  

  • 31. [Metformin and kidney].
    Sessa C; Blanco J; Granata A; Fatuzzo P; Castellino P; Zanoli L
    G Ital Nefrol; 2016; 33(3):. PubMed ID: 27374392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Newer anti - diabetic therapies and chronic kidney disease].
    Di Lullo L; Ronco C; Barbera V; Cozzolino M; Santoboni F; Villani A; De Pascalis A; Bellasi A
    G Ital Nefrol; 2017; 34(1):. PubMed ID: 28177092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An update on the comparative effectiveness and safety of medications for type 2 diabetes.
    Goldstein MR; Mascitelli L
    Ann Intern Med; 2011 Oct; 155(8):562-3; author reply 563. PubMed ID: 22007052
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cardiovascular and renal protection of patients with type 2 diabetes : focus after EMPA-REG OUTCOME and LEADER].
    Scheen AJ; Piérard L; Krzesinski JM; Paquot N
    Rev Med Liege; 2016 Sep; 71(9):376-381. PubMed ID: 28383832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SGLT2 inhibitors and renal function.
    Med Lett Drugs Ther; 2016 Jul; 58(1499):91-2. PubMed ID: 27403782
    [No Abstract]   [Full Text] [Related]  

  • 36. 30 things you should know about managing diabetes.
    Bunker K
    Diabetes Forecast; 2008 Apr; 61(4):54-6. PubMed ID: 18478645
    [No Abstract]   [Full Text] [Related]  

  • 37. Antidiabetic medications and polypharmacy.
    Peron EP; Ogbonna KC; Donohoe KL
    Clin Geriatr Med; 2015 Feb; 31(1):17-27, vii. PubMed ID: 25453298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Insulin therapy in type 2 diabetes].
    Philips JC; Scheen AJ
    Rev Med Liege; 2005; 60(5-6):419-23. PubMed ID: 16035304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diabetes treatment in patients with chronic kidney disease].
    Süfke S; Steinhoff J; Schütt M
    Dtsch Med Wochenschr; 2013 May; 138(21):1109-18; quiz 1119-22. PubMed ID: 23677506
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pioglitazone protects the type-2-diabetes patient from myocardial infarction and stroke].
    MMW Fortschr Med; 2007 Aug; 149(31-32):52-3. PubMed ID: 17849787
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.